4 Patents
- US126114092026Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1/PD-L1 Inhibitor
CHEMOCENTRYX, Inc.
0 cites - 0 cites
- US118833912024Compositions and Methods for Treating Inflammatory Bowel Disease Using CCR9 Inhibitor and Anti-il-23 Blocking Antibodies
CHEMOCENTRYX, Inc.
0 cites - US117448222023Reducing Tumor Burden by Administering CCR1 Antagonists in Combination with PD-1 Inhibitors or PD-L1 Inhibitors
CHEMOCENTRYX, Inc.
0 cites